Clinical Trials

NCT07038369 | ACTIVE_NOT_RECRUITING | PHASE1
134 participants

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2025-07-29
Completion:
2028-08-31
Conditions
  • Advanced Solid Tumors
  • Breast Cancer
  • Breast Carcinoma
  • Breast Neoplasms
  • ER Positive Breast Cancer
  • Cervical Cancers
  • Cervical Neoplasms
  • Cervical Carcinoma
  • Triple Negative Breast Cancer
  • Gynecologic Cancers
  • Gynecologic Neoplasm
  • Endometrial Cancer
  • Endometrial Neoplasm
  • Endometrial Carcinoma (EC)
  • Fallopian Cancer
  • Ovarian Carcinoma
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Prostate Cancers
  • Prostate Carcinoma
  • Solid Tumors
  • Neoplasms
  • Neoplasms by Site
  • Breast Diseases
  • Uterine Neoplasms
  • Genital Neoplasms, Female
  • Urogenital Neoplasms
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
NCT06976138 | RECRUITING | NA
252 participants

Sleep TO Prevent Post-surgical Pain

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2025-06-13
Completion:
2029-07-31
Conditions
  • Knee Osteoarthristis
Interventions
  • BEHAVIORAL
  • DEVICE
No Results Yet
NCT06973811 | RECRUITING | PHASE2
47 participants

ZR-MTX for PIOL Phase II Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2025-05-21
Completion:
2027-10-30
Conditions
  • Primary Intraocular Lymphoma
Interventions
  • DRUG
No Results Yet
NCT06900595 | RECRUITING | PHASE2
48 participants

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2026-02-22
Completion:
2029-06-02
Conditions
  • Locally Advanced Adrenal Cortical Carcinoma
  • Metastatic Adrenal Cortical Carcinoma
  • Recurrent Adrenal Cortical Carcinoma
  • Stage III Adrenal Cortical Carcinoma AJCC v8
  • Stage IV Adrenal Cortical Carcinoma AJCC v8
  • Unresectable Adrenal Cortical Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06880055 | RECRUITING
3375 participants

Shield Post-Approval Study Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-07
Start Date:
2025-07-14
Completion:
2030-09-01
Conditions
  • Colo-rectal Cancer
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page